The Dutch biotech industry: from start-up to exit

16/01/12 – The Netherlands Biotech Industry Association Niaba and leading Benelux law firm NautaDutilh are jointly organising a seminar to highlight and discuss trends, strengths and weaknesses in the current entrepreneurial environment for the biotech industry in the Netherlands. ‘The Dutch biotech industry: from start-up to exit’, will be held on 9 May 2012 in Amsterdam from 14.00 onwards. The speakers at the seminar will be:

• Ronald Brus, today CEO of Crucell (future life sciences entrepreneur),
• Onno van de Stolpe, CEO of Galapagos,
• René Kuijten, partner at Life Sciences Partners,
• Hans Clevers, professor of molecular genetics at the Hubrecht Institute,
• Paul Huijts, director-general at the Ministry of Health,
• Oscar Izeboud, Head of Life Sciences at Kempen & Co,
• Maurice Laudy, Head of Healthcare, ABN AMRO Corporate Finance & Capital Markets,
• Christiaan de Brauw, Head of Life Sciences team and partner NautaDutilh.

To register for the seminar, please send an email to aboutyou[at]nautadutilh[dot]com